Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humacyte (HUMA) Inventory (2025)

Humacyte has reported Inventory over the past 1 years, most recently at $22.5 million for Q4 2025.

  • Quarterly results put Inventory at $22.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $22.5 million (changed N/A YoY), and the annual figure for FY2025 was $22.5 million, changed.
  • Inventory for Q4 2025 was $22.5 million at Humacyte, up from $18.4 million in the prior quarter.
  • Over the last five years, Inventory for HUMA hit a ceiling of $22.5 million in Q4 2025 and a floor of $8.0 million in Q1 2025.